234 related articles for article (PubMed ID: 28559023)
21. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients.
Huang CL; Xu C; Zhang Y; Zhou GQ; Mao YP; Liu Q; Sun Y; Ma J; Tang LL
Radiat Oncol; 2018 Aug; 13(1):141. PubMed ID: 30081932
[TBL] [Abstract][Full Text] [Related]
23. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
[TBL] [Abstract][Full Text] [Related]
24. High-risk factors of parotid lymph node metastasis in nasopharyngeal carcinoma: a case-control study.
Wang HZ; Cao CN; Luo JW; Yi JL; Huang XD; Zhang SP; Wang K; Qu Y; Xiao JP; Li SY; Gao L; Xu GZ
Radiat Oncol; 2016 Sep; 11(1):113. PubMed ID: 27586641
[TBL] [Abstract][Full Text] [Related]
25. [Prophylactic irradiation at the level Ib for nasopharyngeal carcinoma: should that be a routine?].
Tan JM; Liang Y; Zhao C; Li MY; Liu JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1989-92. PubMed ID: 22200697
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Mao YP; Tang LL; Chen L; Sun Y; Qi ZY; Zhou GQ; Liu LZ; Li L; Lin AH; Ma J
Chin J Cancer; 2016 Dec; 35(1):103. PubMed ID: 28031050
[TBL] [Abstract][Full Text] [Related]
27. Suggestions for lymph node classification of UICC/AJCC staging system: a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Guo Q; Pan J; Zong J; Zheng W; Zhang C; Tang L; Chen B; Cui X; Xiao Y; Chen Y; Lin S
Medicine (Baltimore); 2015 May; 94(20):e808. PubMed ID: 25997052
[TBL] [Abstract][Full Text] [Related]
28. Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma.
Chen JZ; Le QT; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Cui NJ; Zhao C
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):929-34. PubMed ID: 22975606
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
Guan X; Wang X; Liu Y; Hu C; Zhu G
Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
[TBL] [Abstract][Full Text] [Related]
31. Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.
Shi Q; Shen C; Kong L; Wang X; Ding J; Gao Y; Xu T; Hu C
Radiat Oncol; 2014 Jan; 9():7. PubMed ID: 24393418
[TBL] [Abstract][Full Text] [Related]
32. Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.
Lin F; Qiu Z; Xie D; Zhou X; Wang L; Wu Z; Cheng W; Lyu S; Su Y; Tao Y
Cancer Med; 2023 Nov; 12(21):20511-20520. PubMed ID: 37881136
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy.
Zhou GQ; Mao YP; Chen L; Li WF; Liu LZ; Sun Y; Chen Y; Tian L; Lin AH; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1090-7. PubMed ID: 21864993
[TBL] [Abstract][Full Text] [Related]
34. Added value of metastatic cervical lymph node group V in nodal staging of nasopharyngeal cancer.
Setakornnukul J; Thephamongkhol K; Chaysiri P
Head Neck; 2020 Oct; 42(10):2801-2810. PubMed ID: 32542997
[TBL] [Abstract][Full Text] [Related]
35. A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma.
Li JG; Yuan X; Zhang LL; Tang YQ; Liu L; Chen XD; Gong XC; Wan GF; Liao YL; Ye JM; Ao F
Cancer; 2013 Sep; 119(17):3170-6. PubMed ID: 23765713
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
Zhang Y; Li WF; Chen L; Mao YP; Guo R; Zhang F; Peng H; Liu LZ; Li L; Liu Q; Ma J
Sci Rep; 2015 Sep; 5():13919. PubMed ID: 26345410
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
Liao JF; Ma L; Du XJ; Lan M; Guo Y; Zheng L; Xia YF; Luo W
PLoS One; 2016; 11(1):e0146787. PubMed ID: 26824230
[TBL] [Abstract][Full Text] [Related]
38. Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
[TBL] [Abstract][Full Text] [Related]
39. Evidence on Effectiveness of Upper Neck Irradiation Versus Whole Neck Irradiation as Elective Neck Irradiation in Node-Negative Nasopharyngeal Cancer: A Meta-Analysis.
Co JL; Mejia MBA; Dizon JMR
J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241188
[TBL] [Abstract][Full Text] [Related]
40. Clinical treatment considerations in the intensity-modulated radiotherapy era for patients with N0-category nasopharyngeal carcinoma and enlarged neck lymph nodes.
Peng H; Chen L; Guo R; Zhang Y; Li WF; Mao YP; Sun Y; Zhang F; Liu LZ; Tian L; Ma J
Chin J Cancer; 2017 Mar; 36(1):32. PubMed ID: 28340596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
